Search Results 1271-1280 of 14241 for risksas

  1. Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer - Mayo Clinic

    About this study. The safety and effectiveness of TheraSphere will be evaluated in patients with unresectable hepatocellular carcinoma in whom treatment ...

  2. Cardiovascular Medicine - Clinical trials

    Rochester, Minn. The purpose of this study is to utilize three dimensional (3D) transesophageal echocardiography (TEE) or 3D transthoracic echocardiography (TTE) ...

  3. A Study to Evaluate The Negative Predictive Value and Non-irritant Skin Testing Concentrations of Antibiotics - Mayo Clinic

    The purpose of this study is to accurately determine the negative predictive value of skin testing with antibiotics. Participation eligibility. Participant ...

  4. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    The purpose of this study is to see how well lorvotuzumab mertansine works in treating younger patients with Wilms tumor, rhabdomyosarcoma, neuroblastoma, ...

  5. Early Identification Of Chemotherapy Induced Cardiac Toxicity - Mayo Clinic

    Mitral valve inflow velocities (E, A) and mitral annular tissue Doppler (e', a'). Tricuspid tissue velocities and TAPSE. The study will also determine whether ...

  6. A Study To Evaluate Long Term Change In Tau Deposits By Comparing New Scans With 18F-AV-1451 Uptake, To Scans From Previous Study 18F-AV-1451-A05 - Mayo Clinic

    Participation eligibility · Current clinically significant cardiovascular disease, ECG abnormalities, risk factors for Torsades de Pointes, or are taking drugs ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52) - Mayo Clinic

    This is a study using pembrolizumab (MK-3475, KEYTRUDA®) for first-line treatment of participants with advanced/unresectable (inoperable) or metastatic ...

  9. A Study of Outcomes for Patients and Caregivers Receiving Bone Marrow Transplant (BMT) by Providing a Caregiving Educational Intervention - Mayo Clinic

    The goal of this project is to improve outcomes for patients receiving bone marrow transplant (BMT) and their caregivers by providing a caregiving educational ...

  10. Quality-Adjusted Survival in Allogeneic Hematopoietic Cell Transplant Patients - Mayo Clinic

    The utilization of hematopoietic cell transplantation (HCT) has increased dramatically over the past decade. Although it is potentially lifesaving for a variety ...